Hoyne, G., Rudnicka, C., Sang, Q., Roycik, M., Howarth, S., Leedman, P., . . . Matthews, V. (2016). Genetic and cellular studies highlight that A Disintegrin and Metalloproteinase 19 is a protective biomarker in human prostate cancer. BMC Cancer.

Hoyne, Gerard, Caroline Rudnicka, Qing-Xiang Sang, Mark Roycik, Sarah Howarth, Peter Leedman, Markus Schlaich, Patrick Candy, and Vance Matthews. "Genetic and Cellular Studies Highlight That A Disintegrin and Metalloproteinase 19 Is a Protective Biomarker in Human Prostate Cancer." BMC Cancer 2016.

Hoyne, Gerard, et al. "Genetic and Cellular Studies Highlight That A Disintegrin and Metalloproteinase 19 Is a Protective Biomarker in Human Prostate Cancer." BMC Cancer 2016.